Pharming Group Nv (PHAR) has released an update.
Pharming Group N.V. has announced the early redemption of their outstanding €125 million 3.00% convertible bonds due in 2025, with a redemption date set for June 18, 2024. This redemption follows the company’s repurchase of €123.1 million in aggregate principal amount of these bonds on April 26, 2024. Bondholders have the option to convert their bonds into ordinary shares at a conversion price of €2.0028 per share until June 7, 2024.
For further insights into PHAR stock, check out TipRanks’ Stock Analysis page.
